sulfur-NSAID COX inhibitors series (Sulfidris)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namesulfur-NSAID COX inhibitors series (Sulfidris)
Drug Alias NameS-sulindacACS-18ACS-27
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsColonic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCTG Pharma Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCTG Pharma SrlSulfidris Srl
Active IndicationsN/A
Inactive IndicationsColonic NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A